Cochrane · systematic review · CD012329
Oxycodone for pain in fibromyalgia in adults
Gaskell, H, Moore, RA, Derry, S, et al. · Cochrane Database of Systematic Reviews · 2016 · Cochrane Library
Pain, Palliative and Supportive CareAMSTAR 2: not assessed
SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
6
current version
GRADE rated
6
No studies
0
Included studies
NR
No studies 0 · 0%Ungraded 0 · 0%Very low 6 · 100%Low 0 · 0%Moderate 0 · 0%High 0 · 0%
Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.
Questions and results
Oxycodone compared with placebo for fibromyalgia
Population: adults with fibromyalgia
| Outcome | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Moderate benefit: At least 30% reduction in pain, or PGIC much or very much improved Oxycodone vs placebo | no estimate extracted | NR | Very low |
Substantial benefit: At least 50% reduction in pain, or PGIC much improved Oxycodone vs placebo | no estimate extracted | NR | Very low |
Lack of efficacy withdrawal Oxycodone vs placebo | no estimate extracted | NR | Very low |
Adverse event withdrawal Oxycodone vs placebo | no estimate extracted | NR | Very low |
Serious adverse events Oxycodone vs placebo | no estimate extracted | NR | Very low |
Deaths Oxycodone vs placebo | no estimate extracted | NR | Very low |